Papers: 10.1038/s41375-019-0395-y
https://doi.org/10.1038/s41375-019-0395-y
Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine
Cited by: 7
Author(s): Richard F. Schlenk, Daniela Weber, Wolfgang Herr, Gerald Wulf, Helmut R. Salih, Hans-Günter Derigs, Andrea Kuendgen, Mark Ringhoffer, Bernd Hertenstein, Uwe M. Martens, Martin Grießhammer, Helga Bernhard, Jürgen Krauter, Michael Girschikofsky, Dominik Wolf, Elisabeth Lange, Joerg Westermann, Elisabeth Koller, Stephan Kremers, Mohammed Wattad, Michael Heuser, Felicitas Thol, Gudrun Göhring, D. Haase, Veronica Teleanu, Verena I. Gaidzik, Axel Benner, Konstanze Döhner, Arnold Ganser, Peter Paschka, Hartmut Döhner
Published: almost 8 years ago